{"certainAgreement":{"otherDetails":"The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 12 months but less than 18 months from the end of study (database lock).The sponsor cannot require changes to the communication and cannot extend the embargo.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Results of the biweekly dosing regimens are based on the Clinical Study Report."},"pointOfContact":{"email":"clinicaltrials@genmab.com","organization":"Genmab","phone":"+45 7020 2728","title":"Clinical Trial Information"}}